FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Garrett Brodeur

Research Profile

Disorders

Genes & Molecular Sequences

Anatomy

Physiology

Living Beings

Infants

Chemicals & Drugs

Concepts & Ideas

Procedures

Chromosome Mapping

Co-author Network

Publications

TOP 3
Radhika Iyer; Jennifer E Light; Jane E. Minturn; Anisha M Simpson; Kenneth Thress; Carly R Varela; Huaqing Zhao; Jeffrey L Brown; Audrey E Evans; Ruth Ho; Garrett M Brodeur
AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.
Jennifer E Light; Wendy B London; Jennifer L Mangino; Jane E. Minturn; Anisha M Simpson; Ruth Ho; Radhika Iyer; Venkatadri Kolla; Hiroshi Koyama; Garrett M Brodeur
Clinical significance of NTRK family gene expression in neuroblastomas.
Hiroshi Koyama; Jennifer E Light; Wendy B London; Patrick W McGrady; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla; Garrett M Brodeur
Mechanisms of CHD5 Inactivation in neuroblastomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Garrett Brodeur (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Radhika Iyer; Jennifer E Light; Jane E. Minturn; Anisha M Simpson; Kenneth Thress; Carly R Varela; Huaqing Zhao; Jeffrey L Brown; Audrey E Evans; Ruth Ho; Garrett M Brodeur
AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.
Cancer chemotherapy and pharmacology 2012;70(3):477-86.
2012: Jennifer E Light; Wendy B London; Jennifer L Mangino; Jane E. Minturn; Anisha M Simpson; Ruth Ho; Radhika Iyer; Venkatadri Kolla; Hiroshi Koyama; Garrett M Brodeur
Clinical significance of NTRK family gene expression in neuroblastomas.
Pediatric blood & cancer 2012;59(2):226-32.
2012: Hiroshi Koyama; Jennifer E Light; Wendy B London; Patrick W McGrady; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla; Garrett M Brodeur
Mechanisms of CHD5 Inactivation in neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(6):1588-97.
2011: Robin E Norris; Garrett M Brodeur; John M Maris; Jane E. Minturn; Peter Charles Adamson
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Cancer chemotherapy and pharmacology 2011;68(6):1469-75.
2011: Jane E. Minturn; Julie R Park; Suzanne Shusterman; Judith G Villablanca; Gregory Yanik; Debra Bensen-Kennedy; Garrett M Brodeur; Audrey E Evans; Susan Groshen; Edward T Hellriegel; Katherine K Matthay; John M Maris
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.
Cancer chemotherapy and pharmacology 2011;68(4):1057-65.
2011: Garrett M Brodeur
Knowing your ABCCs: novel functions of ABCC transporters.
Journal of the National Cancer Institute 2011;103(16):1207-8.
2011: Ruth Ho; Jane E Minturn; Anisha M Simpson; Radhika Iyer; Jennifer E Light; Audrey E Evans; Garrett M Brodeur
The effect of P75 on Trk receptors in neuroblastomas.
Cancer letters 2011;305(1):76-85.
2010: Garrett M Brodeur
Getting into the AKT.
Journal of the National Cancer Institute 2010;102(11):747-9.
2009: Garrett M Brodeur; Jane E. Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Carly R Varela; Jennifer E Light; Venkatadri Kolla; Audrey E Evans
Trk receptor expression and inhibition in neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3244-50.
2008: Yaël P Mossé; Marci Laudenslager; Luca Longo; Kristina A Cole; Andrew Cameron Wood; Edward F Attiyeh; Michael J Laquaglia; Rachel Sennett; Jill E Lynch; Patrizia Perri; Geneviève Laureys; Frank Speleman; Cecilia Kim; Cuiping Hou; Hakon Hakonarson; Ali Torkamani; Nicholas J Schork; Garrett M Brodeur; Gian P Tonini; Eric F Rappaport; Marcella Devoto; John M Maris
Identification of ALK as a major familial neuroblastoma predisposition gene.
Nature 2008;455(7215):930-5.
2008: Tomoyuki Fujita; Jun Igarashi; Erin R Okawa; Takahiro Gotoh; Jayanthi Manne; Venkatadri Kolla; Jessica Kim; Huaqing Zhao; Bruce R Pawel; Wendy B London; John M Maris; Peter White; Garrett M Brodeur
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Journal of the National Cancer Institute 2008;100(13):940-9.
2008: Kristina A Cole; Edward F Attiyeh; Yael P Mosse; Michael J Laquaglia; Sharon J Diskin; Garrett M Brodeur; John M Maris
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
Molecular cancer research : MCR 2008;6(5):735-42.
2008: Jennifer Schneiderman; Wendy B London; Garrett M Brodeur; Robert P Castleberry; A Thomas Look; Susan Cohn
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):913-8.
2008: E R Okawa; T Gotoh; J Manne; J Igarashi; T Fujita; K A Silverman; H Xhao; Yael Mosse; Peter White; Garrett M Brodeur
Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
Oncogene 2008;27(6):803-10.
2006: Qun Wang; Sharon J Diskin; Eric F Rappaport; Edward F Attiyeh; Yael Mosse; Daniel Shue; Eric Seiser; Jayanti Jagannathan; Susanne Shusterman; Manisha Bansal; Deepa Khazi; Cynthia Winter; Erin Okawa; Gregory Grant; Avital Cnaan; Huaqing Zhao; Nai-Kong V Cheung; William Gerald; Wendy London; Katherine K Matthay; Garrett M Brodeur; John M Maris
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Cancer research 2006;66(12):6050-62.
2005: Rochelle Bagatell; Pavlina Rumcheva; Wendy B London; Susan Cohn; A Thomas Look; Garrett M Brodeur; Christopher Frantz; Vijay Joshi; Paul Thorner; P V Rao; Robert P Castleberry; Laura C Bowman
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8819-27.
2005: Edward F Attiyeh; Wendy B London; Yael P Mossé; Qun Wang; Cynthia Winter; Deepa Khazi; Patrick W McGrady; Robert C Seeger; A Thomas Look; Hiroyuki Shimada; Garrett M Brodeur; Susan Cohn; Katherine K Matthay; John M Maris
Chromosome 1p and 11q deletions and outcome in neuroblastoma.
The New England journal of medicine 2005;353(21):2243-53.
2005: Rose Ho; Jane E. Minturn; Tomoro Hishiki; Huaqing Zhao; Qun Wang; Avital Cnaan; John M Maris; Audrey E Evans; Garrett M Brodeur
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.
Cancer research 2005;65(21):9868-75.
2005: Wendy B London; Robert P Castleberry; K K Matthay; A Thomas Look; Robert C Seeger; H Shimada; Paul Thorner; Garrett M Brodeur; John M Maris; Charles Patrick Reynolds; Susan Cohn
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6459-65.
2005: Rani E George; Wendy B London; Susan Cohn; John M Maris; Cynthia S Kretschmar; Lisa Diller; Garrett M Brodeur; Robert P Castleberry; A Thomas Look
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6466-73.
2005: Peter White; Patricia M Thompson; Takahiro Gotoh; Erin R Okawa; Jun Igarashi; Marleen Kok; Cynthia Winter; Simon G Gregory; Michael D Hogarty; John M Maris; Garrett M Brodeur
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
Oncogene 2005;24(16):2684-94.
2004: Erik P Sulman; Peter White; Garrett M Brodeur
Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34.
Oncogene 2004;23(4):1014-20.
2003: Garrett M Brodeur
Neuroblastoma: biological insights into a clinical enigma.
Nature reviews. Cancer 2003;3(3):203-16.
2003: Patricia M Thompson; Takahiro Gotoh; Marleen Kok; Peter White; Garrett M Brodeur
CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
Oncogene 2003;22(7):1002-11.
2002: John M Maris; Mitchell J Weiss; Yael Mosse; George Hii; Chun Guo; Peter White; Michael D Hogarty; Tamar Mirensky; Garrett M Brodeur; Timothy R Rebbeck; Margrit Urbanek; Susanne Shusterman
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
Cancer research 2002;62(22):6651-8.
2002: Michael D Hogarty; Cynthia L Winter; Xueyuan Liu; Chun Guo; Peter White; A Thomas Look; Garrett M Brodeur; John M Maris
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Cancer research 2002;62(22):6481-4.
2002: Rose Ho; Angelika Eggert; Tomoro Hishiki; Jane E. Minturn; Naohiko Ikegaki; Patricia Foster; Anna Marie Camoratto; Audrey E Evans; Garrett M Brodeur
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Cancer research 2002;62(22):6462-6.
2002: Angelika Eggert; Michael A Grotzer; Naohiko Ikegaki; Xing-ge Liu; Audrey E Evans; Garrett M Brodeur
Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Cancer research 2002;62(6):1802-8.
2002: Garrett M Brodeur
Significance of intratumoral genetic heterogeneity in neuroblastomas.
Medical and pediatric oncology 2002;38(2):112-3.
2002: Angelika Eggert; Michael A Grotzer; TJ Zuzak; Naohiko Ikegaki; Huaqing Zhao; Garrett M Brodeur
Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system.
European journal of cancer (Oxford, England : 1990) 2002;38(1):92-8.
2001: S Goto; S Umehara; Robert B Gerbing; Daniel O Stram; Garrett M Brodeur; Robert C Seeger; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 2001;92(10):2699-708.
2001: Michael A Grotzer; Michael D Hogarty; Anna Janss; X Liu; Huaqing Zhao; Angelika Eggert; Leslie N Sutton; Lucy B Rorke; Garrett M Brodeur; Peter C Phillips
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2425-33.
2001: Angelika Eggert; Michael A Grotzer; H Zhao; Garrett M Brodeur; Audrey E Evans
[Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
Klinische Pädiatrie 2001;213(4):191-6.
2001: Prasad Mathew; Marcus B Valentine; Laura C Bowman; ST Rowe; MB Nash; Virginia Valentine; Susan Cohn; Robert P Castleberry; Garrett M Brodeur; A Thomas Look
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
Neoplasia (New York, N.Y.) 2001;3(2):105-9.
2001: Angelika Eggert; Michael A Grotzer; TJ Zuzak; BR Wiewrodt; Rose Ho; Naohiko Ikegaki; Garrett M Brodeur
Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
Cancer research 2001;61(4):1314-9.
2001: Angelika Eggert; Michael A Grotzer; Naohiko Ikegaki; Huaqing Zhao; Avital Cnaan; Garrett M Brodeur; Audrey E Evans
Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):689-96.
2001: P M Thompson; John M Maris; Michael D Hogarty; Robert C Seeger; Charles Patrick Reynolds; Garrett M Brodeur; Peter White
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Cancer research 2001;61(2):679-86.
2001: Xao X Tang; Audrey E Evans; Huaqing Zhao; Avital Cnaan; Garrett M Brodeur; Naohiko Ikegaki
Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
Medical and pediatric oncology 2001;36(1):80-2.
2001: Michael D Hogarty; John M Maris; Peter White; Chun Guo; Garrett M Brodeur
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):52-5.
2001: Peter White; Patricia M Thompson; BA Seifried; Erik P Sulman; SJ Jensen; Chun Guo; John M Maris; Michael D Hogarty; C Allen; Jaclyn A Biegel; Tara C Matise; Simon G Gregory; Charles Patrick Reynolds; Garrett M Brodeur
Detailed molecular analysis of 1p36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):37-41.
2001: John M Maris; Chun Guo; D Blake; Peter White; Michael D Hogarty; Patricia M Thompson; V Rajalingam; Robert B Gerbing; DO Stram; KK Matthay; Robert C Seeger; Garrett M Brodeur
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Medical and pediatric oncology 2001;36(1):32-6.
2001: Patricia M Thompson; BA Seifried; S K Kyemba; SJ Jensen; Chun Guo; John M Maris; Garrett M Brodeur; DO Stram; Robert C Seeger; Robert B Gerbing; KK Matthay; Tara C Matise; Peter White
Loss of heterozygosity for chromosome 14q in neuroblastoma.
Medical and pediatric oncology 2001;36(1):28-31.
2001: John M Maris; Chun Guo; Peter White; Michael D Hogarty; Patricia M Thompson; DO Stram; Robert B Gerbing; KK Matthay; Robert C Seeger; Garrett M Brodeur
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Medical and pediatric oncology 2001;36(1):24-7.
2001: Audrey E Evans; KD Kisselbach; X Liu; Angelika Eggert; Naohiko Ikegaki; Anna Marie Camoratto; Craig Dionne; Garrett M Brodeur
Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
Medical and pediatric oncology 2001;36(1):181-4.
2001: Garrett M Brodeur; A Thomas Look; H Shimada; V M Hamilton; John M Maris; H W Hann; Jean-Marie Leclerc; Mark Bernstein; LC Brisson; Jean-Hugues Brossard; Bernard Lemieux; Mendel Tuchman; William G Woods
Biological aspects of neuroblastomas identified by mass screening in Quebec.
Medical and pediatric oncology 2001;36(1):157-9.
2001: Angelika Eggert; Naohiko Ikegaki; Xing-ge Liu; TT Chou; Garrett M Brodeur
TrkA signal transduction pathways in neuroblastoma.
Medical and pediatric oncology 2001;36(1):108-10.
2000: Xao X Tang; Huaqing Zhao; Marjorie E Robinson; Avital Cnaan; W London; Susan Cohn; Nai-Kong V Cheung; Garrett M Brodeur; Audrey E Evans; Naohiko Ikegaki
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.
Medical and pediatric oncology 2000;35(6):656-8.
2000: Angelika Eggert; Rose Ho; Naohiko Ikegaki; Xing-ge Liu; Garrett M Brodeur
Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.
Medical and pediatric oncology 2000;35(6):623-7.
2000: Angelika Eggert; Michael A Grotzer; TJ Zuzak; BR Wiewrodt; Naohiko Ikegaki; Garrett M Brodeur
Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
Medical and pediatric oncology 2000;35(6):603-7.
2000: D Huang; JL Rutkowski; Garrett M Brodeur; P M Chou; Janet Kwiatkowski; A Babbo; Susan Cohn
Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo.
Medical and pediatric oncology 2000;35(6):590-2.
2000: Angelika Eggert; Hauke Sieverts; Naohiko Ikegaki; Garrett M Brodeur
p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.
Medical and pediatric oncology 2000;35(6):573-6.
2000: Angelika Eggert; Michael A Grotzer; Naohiko Ikegaki; Xing-ge Liu; Audrey E Evans; Garrett M Brodeur
Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.
Medical and pediatric oncology 2000;35(6):569-72.
2000: Michael D Hogarty; X Liu; Patricia M Thompson; Peter White; Erik P Sulman; John M Maris; Garrett M Brodeur
BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
Medical and pediatric oncology 2000;35(6):559-62.
2000: Chun Guo; Peter White; Michael D Hogarty; Garrett M Brodeur; Robert B Gerbing; Daniel O Stram; John M Maris
Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.
Medical and pediatric oncology 2000;35(6):544-6.
2000: Mitchell J Weiss; Chun Guo; Susanne Shusterman; George Hii; T L Mirensky; Peter White; Michael D Hogarty; Timothy R Rebbeck; D Teare; M Urbanek; Garrett M Brodeur; John M Maris
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.
Medical and pediatric oncology 2000;35(6):526-30.
2000: Michael D Hogarty; X Liu; Chun Guo; Patricia M Thompson; Mitchell J Weiss; Peter White; Erik P Sulman; Garrett M Brodeur; John M Maris
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
Medical and pediatric oncology 2000;35(6):512-5.
2000: D Huang; JL Rutkowski; Garrett M Brodeur; P M Chou; Janet Kwiatkowski; A Babbo; Susan Cohn
Schwann cell-conditioned medium inhibits angiogenesis.
Cancer research 2000;60(21):5966-71.
2000: Xao X Tang; Huaqing Zhao; Marjorie E Robinson; B Cohen; Avital Cnaan; W London; Susan Cohn; Nai-Kong V Cheung; Garrett M Brodeur; Audrey E Evans; Naohiko Ikegaki
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10936-41.
2000: Michael A Grotzer; Angelika Eggert; TJ Zuzak; Anna Janss; S Marwaha; BR Wiewrodt; Naohiko Ikegaki; Garrett M Brodeur; Peter C Phillips
Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
Oncogene 2000;19(40):4604-10.
2000: Angelika Eggert; Naohiko Ikegaki; X G Liu; Garrett M Brodeur
Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Klinische Pädiatrie 2000;212(4):200-5.
2000: CS Alvarado; Wendy B London; A Thomas Look; Garrett M Brodeur; D H Altmiller; Paul Thorner; Vijay V Joshi; ST Rowe; MB Nash; E Ide Smith; Robert P Castleberry; Susan Cohn
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Journal of pediatric hematology/oncology 2000;22(3):197-205.
2000: Angelika Eggert; Naohiko Ikegaki; Janet Kwiatkowski; Huaqing Zhao; Garrett M Brodeur; Bruce P Himelstein
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1900-8.
2000: John M Maris; Mitchell J Weiss; Chun Guo; Robert B Gerbing; Daniel O Stram; Peter White; Michael D Hogarty; Erik P Sulman; Patricia M Thompson; John N Lukens; Katherine K Matthay; Robert C Seeger; Garrett M Brodeur
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1888-99.
2000: Angelika Eggert; Naohiko Ikegaki; X Liu; TT Chou; Virginia M-Y Lee; John Q Trojanowski; Garrett M Brodeur
Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Oncogene 2000;19(16):2043-51.
2000: Mary Lou Schmidt; John N Lukens; Robert C Seeger; Garrett M Brodeur; Hiroyuki Shimada; Robert B Gerbing; Daniel O Stram; C Perez; Gerald M Haase; Katherine K Matthay
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1260-8.
2000: H James Nickerson; Katherine K Matthay; Robert C Seeger; Garrett M Brodeur; H Shimada; C Perez; JB Atkinson; Michael T Selch; Robert B Gerbing; Daniel O Stram; John N Lukens
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):477-86.
1999: Audrey E Evans; KD Kisselbach; DJ Yamashiro; Naohiko Ikegaki; Anna Marie Camoratto; Craig Dionne; Garrett M Brodeur
Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3594-602.
1999: Katherine K Matthay; Judith G Villablanca; Robert C Seeger; Daniel O Stram; R E Harris; N K Ramsay; Patrick S Swift; Hiroyuki Shimada; CT Black; Garrett M Brodeur; Robert B Gerbing; Charles Patrick Reynolds
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
The New England journal of medicine 1999;341(16):1165-73.
1999: Chun Guo; Peter White; Mitchell J Weiss; Michael D Hogarty; Patricia M Thompson; DO Stram; Robert B Gerbing; KK Matthay; Robert C Seeger; Garrett M Brodeur; John M Maris
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Oncogene 1999;18(35):4948-57.
1999: Xao X Tang; Audrey E Evans; Huaqing Zhao; Avital Cnaan; W London; Susan Cohn; Garrett M Brodeur; Naohiko Ikegaki
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1491-6.
1999: S G DuBois; Y Kalika; John N Lukens; Garrett M Brodeur; Robert C Seeger; JB Atkinson; Gerald M Haase; CT Black; C Perez; Hiroyuki Shimada; Robert B Gerbing; Daniel O Stram; Katherine K Matthay
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
Journal of pediatric hematology/oncology 1999;21(3):181-9.
1999: X T Kong; Virginia Valentine; ST Rowe; Marcus B Valentine; ST Ragsdale; B G Jones; D A Wilkinson; Garrett M Brodeur; Susan Cohn; A Thomas Look
Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.
Neoplasia (New York, N.Y.) 1999;1(1):80-9.
1999: Xao X Tang; Garrett M Brodeur; B G Campling; Naohiko Ikegaki
Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):455-60.
1998: H Komuro; Marcus B Valentine; ST Rowe; Vincent J Kidd; S Makino; Garrett M Brodeur; Susan Cohn; A Thomas Look
Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
Journal of pediatric surgery 1998;33(11):1695-8.
1998: Michael D Hogarty; Peter White; Erik P Sulman; Garrett M Brodeur
Mononucleotide repeat instability is infrequent in neuroblastoma.
Cancer genetics and cytogenetics 1998;106(2):140-3.
1998: Janet Kwiatkowski; JL Rutkowski; DJ Yamashiro; Gihan I. Tennekoon; Garrett M Brodeur
Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation.
Cancer research 1998;58(20):4602-6.
1998: J L Reiter; Garrett M Brodeur
MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas.
Genes, chromosomes & cancer 1998;23(2):134-40.
1998: Erik P Sulman; Jan P Dumanski; Peter White; Huaqing Zhao; John M Maris; Tiit Mathiesen; Carl Bruder; Avital Cnaan; Garrett M Brodeur
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
Cancer research 1998;58(15):3226-30.
1998: Xao X Tang; David Pleasure; Garrett M Brodeur; Naohiko Ikegaki
A variant transcript encoding an isoform of the human protein tyrosine kinase EPHB2 is generated by alternative splicing and alternative use of polyadenylation signals.
Oncogene 1998;17(4):521-6.
1998: Howard M Katzenstein; Laura C Bowman; Garrett M Brodeur; Paul Thorner; Vijay V Joshi; E Ide Smith; A Thomas Look; ST Rowe; MB Nash; T Holbrook; C Alvarado; P V Rao; Robert P Castleberry; Susan Cohn
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2007-17.
1998: Katherine K Matthay; C Perez; Robert C Seeger; Garrett M Brodeur; Hiroyuki Shimada; JB Atkinson; CT Black; Robert B Gerbing; Gerald M Haase; Daniel O Stram; Patrick S Swift; John N Lukens
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1256-64.
1998: Peter White; SJ Jensen; V Rajalingam; D Stairs; Erik P Sulman; John M Maris; Jaclyn A Biegel; R Wooster; Garrett M Brodeur
Physical mapping of the CA6, ENO1, and SLC2A5 (GLUT5) genes and reassignment of SLC2A5 to 1p36.2.
Cytogenetics and cell genetics 1998;81(1):60-4.
1997: Robert P Castleberry; J Pritchard; P Ambros; F Berthold; Garrett M Brodeur; V Castel; Susan Cohn; Bruno De Bernardi; C Dicks-Mireaux; D Frappaz; Gerald M Haase; M Haber; D R Jones; Vijay V Joshi; M Kaneko; J T Kemshead; P Kogner; R E Lee; Katherine K Matthay; J M Michon; R Monclair; Borghild Roald; Robert C Seeger; Peter Shaw; J J Shuster
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2113-6.
1997: William G Woods; Mendel Tuchman; L L Robison; M Bernstein; Jean-Marie Leclerc; LC Brisson; Jean-Hugues Brossard; G Hill; J Shuster; Russell V Luepker; T Byrne; S Weitzman; G Bunin; Bernard Lemieux; Garrett M Brodeur
Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2106-12.
1997: DJ Yamashiro; Xing-ge Liu; C P Lee; A Nakagawara; Naohiko Ikegaki; L M McGregor; Stephen B Baylin; Garrett M Brodeur
Expression and function of Trk-C in favourable human neuroblastomas.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2054-7.
1997: John M Maris; J Jensen; Erik P Sulman; C P Beltinger; C Allen; Jaclyn A Biegel; Garrett M Brodeur; Peter White
Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?
European journal of cancer (Oxford, England : 1990) 1997;33(12):1991-6.
1997: Peter White; John M Maris; Erik P Sulman; SJ Jensen; S M Kyemba; C P Beltinger; C Allen; DL Kramer; Jaclyn A Biegel; Garrett M Brodeur
Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1957-61.
1997: John M Maris; S M Kyemba; T R Rebbeck; Peter White; Erik P Sulman; SJ Jensen; C Allen; Jaclyn A Biegel; Garrett M Brodeur
Molecular genetic analysis of familial neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1923-8.
1997: R A Altura; John M Maris; H Li; J M Boyett; Garrett M Brodeur; A Thomas Look
Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization.
Genes, chromosomes & cancer 1997;19(3):176-84.
1997: SJ Jensen; Erik P Sulman; John M Maris; Tara C Matise; P J Vojta; J C Barrett; Garrett M Brodeur; Peter White
An integrated transcript map of human chromosome 1p35-p36.
Genomics 1997;42(1):126-36.
1997: Laura C Bowman; Robert P Castleberry; A Cantor; Vijay Joshi; Susan Cohn; E Ide Smith; Alice L Yu; Garrett M Brodeur; F A Hayes; A Thomas Look
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Journal of the National Cancer Institute 1997;89(5):373-80.
1997: Garrett M Brodeur; John M Maris; DJ Yamashiro; Michael D Hogarty; Peter White
Biology and genetics of human neuroblastomas.
Journal of pediatric hematology/oncology 1997;19(2):93-101.
1997: Erik P Sulman; Xao X Tang; C Allen; Jaclyn A Biegel; David Pleasure; Garrett M Brodeur; Naohiko Ikegaki
ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers.
Genomics 1997;40(2):371-4.
1997: Jeffery Vance; Tara C Matise; R Wooster; Brian C Schutte; G A Bruns; N van Roy; Garrett M Brodeur; Y X Tao; S Gregory; A Weith; M Vaudin; P White
Report and abstracts of the third international workshop on human chromosome 1 mapping 1997.
Cytogenetics and cell genetics 1997;78(3-4):154-82.
1997: Garrett M Brodeur; A Nakagawara; DJ Yamashiro; Naohiko Ikegaki; Xing-ge Liu; C G Azar; C P Lee; Audrey E Evans
Expression of TrkA, TrkB and TrkC in human neuroblastomas.
Journal of neuro-oncology 1997;31(1-2):49-55.
1997: John M Maris; J Chatten; Anna T Meadows; Jaclyn A Biegel; Garrett M Brodeur
Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease.
Medical and pediatric oncology 1997;28(1):1-5.
1996: H Kuroda; Peter White; Erik P Sulman; C F Manohar; J L Reiter; Susan Cohn; Garrett M Brodeur
Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
Oncogene 1996;13(7):1561-5.
1996: Daniel O Stram; K K Matthay; M O'Leary; Charles Patrick Reynolds; Gerald M Haase; JB Atkinson; Garrett M Brodeur; Robert C Seeger
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2417-26.
1996: John M Maris; S M Kyemba; Timothy R Rebbeck; Peter White; Erik P Sulman; SJ Jensen; C Allen; Jaclyn A Biegel; R A Yanofsky; Gerald L Feldman; Garrett M Brodeur
Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
Cancer research 1996;56(15):3421-5.
1996: John M Maris; SJ Jensen; Erik P Sulman; C P Beltinger; K Gates; C Allen; Jaclyn A Biegel; Garrett M Brodeur; Peter White
Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3.
Genomics 1996;35(2):289-98.
1996: C P Beltinger; Peter White; John M Maris; Erik P Sulman; SJ Jensen; D LePaslier; B J Stallard; D V Goeddel; F J de Sauvage; Garrett M Brodeur
Physical mapping and genomic structure of the human TNFR2 gene.
Genomics 1996;35(1):94-100.
1996: J L Reiter; Garrett M Brodeur
High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.
Genomics 1996;32(1):97-103.
1996: DJ Yamashiro; A Nakagawara; Naohiko Ikegaki; Xing-ge Liu; Garrett M Brodeur
Expression of TrkC in favorable human neuroblastomas.
Oncogene 1996;12(1):37-41.
1996: Andreas Weith; Garrett M Brodeur; G A Bruns; Tara C Matise; Dietmar Mischke; Dean Nizetic; Michael F Seldin; N van Roy; Jeffery Vance
Report of the second international workshop on human chromosome 1 mapping 1995.
Cytogenetics and cell genetics 1996;72(2-3):114-44.
1995: Naohiko Ikegaki; Xao X Tang; Xing-ge Liu; Jaclyn A Biegel; C Allen; A Yoshioka; Erik P Sulman; Garrett M Brodeur; David Pleasure
Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family.
Human molecular genetics 1995;4(11):2033-45.
1995: C F Manohar; Helen R Salwen; Garrett M Brodeur; Susan Cohn
Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
Genes, chromosomes & cancer 1995;14(3):196-203.
1995: John M Maris; Peter White; C P Beltinger; Erik P Sulman; R P Castleberry; J J Shuster; A T Look; Garrett M Brodeur
Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Cancer research 1995;55(20):4664-9.
1995: H Shimada; Daniel O Stram; J Chatten; Vijay V Joshi; Y Hachitanda; Garrett M Brodeur; J N Lukens; K K Matthay; Robert C Seeger
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Journal of the National Cancer Institute 1995;87(19):1470-6.
1995: Xao X Tang; Jaclyn A Biegel; L M Nycum; A Yoshioka; Garrett M Brodeur; David Pleasure; Naohiko Ikegaki
cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.
Genomics 1995;29(2):426-37.
1995: C P Beltinger; Peter White; Erik P Sulman; John M Maris; Garrett M Brodeur
No CDKN2 mutations in neuroblastomas.
Cancer research 1995;55(10):2053-5.
1995: A Nakagawara; J Milbrandt; T Muramatsu; T F Deuel; Huaqing Zhao; Avital Cnaan; Garrett M Brodeur
Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Cancer research 1995;55(8):1792-7.
1995: J A Morris; S J Shcochat; E Ide Smith; A Thomas Look; Garrett M Brodeur; A B Cantor; Robert P Castleberry
Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study.
Journal of pediatric surgery 1995;30(2):296-302; discussion 302-3.
1995: A Nakagawara; Xing-ge Liu; Naohiko Ikegaki; Peter White; DJ Yamashiro; L M Nycum; Jaclyn A Biegel; Garrett M Brodeur
Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).
Genomics 1995;25(2):538-46.
1994: A Nakagawara; C G Azar; N J Scavarda; Garrett M Brodeur
Expression and function of TRK-B and BDNF in human neuroblastomas.
Molecular and cellular biology 1994;14(1):759-67.
1994: N C Dracopoli; G A Bruns; Garrett M Brodeur; Gregory M Landes; Tara C Matise; Michael F Seldin; Jeffery Vance; Andreas Weith
Report and abstracts of the First International Workshop on Human Chromosome 1 Mapping 1994. Bethesda, Maryland, March 25-27, 1994.
Cytogenetics and cell genetics 1994;67(3):144-65.
1994: J L Hiemstra; S S Schneider; Garrett M Brodeur
High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
Progress in clinical and biological research 1994;385():51-7.
1994: J M Cheng; J L Hiemstra; S S Schneider; BA Kaufman; Anna K Naumova; Nai-Kong V Cheung; Susan Cohn; L Diller; Carmen Sapienza; Garrett M Brodeur
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Progress in clinical and biological research 1994;385():43-9.
1994: Garrett M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.
Progress in clinical and biological research 1994;385():363-9.
1994: P S White; M Fujimori; H N Marshall; BA Kaufman; Garrett M Brodeur
Characterization of the region of consistent deletion within 1p36 in neuroblastomas.
Progress in clinical and biological research 1994;385():3-9.
1994: C G Azar; N J Scavarda; A Nakagawara; Garrett M Brodeur
Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Progress in clinical and biological research 1994;385():169-75.
1994: A Nakagawara; M Arima-Nakagawara; C G Azar; N J Scavarda; Garrett M Brodeur
Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma.
Progress in clinical and biological research 1994;385():155-61.
1993: Garrett M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1466-77.
1993: BA Kaufman; P S White; Garrett M Brodeur
A complex single strand conformational polymorphism (SSCP) in the tumor necrosis factor receptor 2 (TNFR2) gene on chromosome 1p36.2.
Human molecular genetics 1993;2(6):824.
1993: M Fujimori; P S White; H N Marshall; Garrett M Brodeur
Simple sequence repeat polymorphism in the cartilage matrix protein (CRTM) gene at 1p35.
Human molecular genetics 1993;2(6):824.
1993: J M Cheng; J L Hiemstra; S S Schneider; Anna K Naumova; Nai-Kong V Cheung; Susan Cohn; L Diller; Carmen Sapienza; Garrett M Brodeur
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Nature genetics 1993;4(2):191-4.
1993: P S White; BA Kaufman; H N Marshall; Garrett M Brodeur
Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma.
Genes, chromosomes & cancer 1993;7(2):102-8.
1993: Vijay V Joshi; A B Cantor; Garrett M Brodeur; A Thomas Look; Jonathan J Shuster; G Altshuler; E W Larkin; C T Holbrook; Jan F Silverman; H T Norris
Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group.
Cancer 1993;71(10):3173-81.
1993: A Nakagawara; M Arima-Nakagawara; N J Scavarda; C G Azar; A B Cantor; Garrett M Brodeur
Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
The New England journal of medicine 1993;328(12):847-54.
1993: Jaclyn A Biegel; Peter White; H N Marshall; M Fujimori; E H Zackai; C D Scher; Garrett M Brodeur; Beverly S Emanuel
Constitutional 1p36 deletion in a child with neuroblastoma.
American journal of human genetics 1993;52(1):176-82.
1992: S S Schneider; J L Hiemstra; B A Zehnbauer; P Taillon-Miller; D L Le Paslier; Bert Vogelstein; Garrett M Brodeur
Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma.
Molecular and cellular biology 1992;12(12):5563-70.
1992: Garrett M Brodeur; C Azar; M Brother; J Hiemstra; B Kaufman; H Marshall; J Moley; A Nakagawara; R Saylors; N Scavarda
Neuroblastoma. Effect of genetic factors on prognosis and treatment.
Cancer 1992;70(6 Suppl):1685-94.
1992: Garrett M Brodeur; A Nakagawara
Molecular basis of clinical heterogeneity in neuroblastoma.
The American journal of pediatric hematology/oncology 1992;14(2):111-6.
1992: C T Fong; P S White; K Peterson; Carmen Sapienza; W K Cavenee; Scott E Kern; Bert Vogelstein; A B Cantor; A T Look; Garrett M Brodeur
Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Cancer research 1992;52(7):1780-5.
1992: A Nakagawara; M Arima; C G Azar; N J Scavarda; Garrett M Brodeur
Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Cancer research 1992;52(5):1364-8.
1992: Jeffrey F Moley; M B Brother; C T Fong; P S White; Stephen B Baylin; Barry D Nelkin; Samuel A Wells; Garrett M Brodeur
Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Cancer research 1992;52(4):770-4.
1992: Jeffrey F Moley; G K Wallin; M B Brother; M Kim; Samuel A Wells; Garrett M Brodeur
Oncogene and growth factor expression in MEN 2 and related tumors.
Henry Ford Hospital medical journal 1992;40(3-4):284-8.
1991: Garrett M Brodeur; J F Moley
Biology of tumors of the peripheral nervous system.
Cancer metastasis reviews 1991;10(4):321-33.
1991: R L Saylors; David Sidransky; H S Friedman; S H Bigner; D D Bigner; Bert Vogelstein; Garrett M Brodeur
Infrequent p53 gene mutations in medulloblastomas.
Cancer research 1991;51(17):4721-3.
1991: Garrett M Brodeur; R L Saylors
Neuroblastoma, retinoblastoma, and brain tumors in children.
Current opinion in oncology 1991;3(3):485-96.
1991: A Thomas Look; F A Hayes; Jonathan J Shuster; E C Douglass; Robert P Castleberry; Laura C Bowman; E Ide Smith; Garrett M Brodeur
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):581-91.
1991: Jeffrey F Moley; M B Brother; Samuel A Wells; B A Spengler; J L Biedler; Garrett M Brodeur
Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
Cancer research 1991;51(6):1596-9.
1991: S S Schneider; B A Zehnbauer; Bert Vogelstein; Garrett M Brodeur
Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
Progress in clinical and biological research 1991;366():71-6.
1991: C Azar; N J Scavarda; Charles Patrick Reynolds; Garrett M Brodeur
Multiple defects of the nerve growth factor receptor in human neuroblastomas.
Progress in clinical and biological research 1991;366():219-26.
1990: Susan Cohn; Helen R Salwen; M W Quasney; Naohiko Ikegaki; J M Cowan; C V Herst; R H Kennett; Steven T Rosen; J A DiGiuseppe; Garrett M Brodeur
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Oncogene 1990;5(12):1821-7.
1990: C G Azar; N J Scavarda; Charles Patrick Reynolds; Garrett M Brodeur
Multiple defects of the nerve growth factor receptor in human neuroblastomas.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(9):421-8.
1990: Garrett M Brodeur
Neuroblastoma--clinical applications of molecular parameters.
Brain pathology (Zurich, Switzerland) 1990;1(1):47-54.
1990: J C Wasson; R L Saylors; P Zeltzer; H S Friedman; S H Bigner; Peter C Burger; D D Bigner; A T Look; E C Douglass; Garrett M Brodeur
Oncogene amplification in pediatric brain tumors.
Cancer research 1990;50(10):2987-90.
1990: Garrett M Brodeur
Neuroblastoma: clinical significance of genetic abnormalities.
Cancer surveys 1990;9(4):673-88.
1989: Garrett M Brodeur
Clinical significance of genetic rearrangements in human neuroblastomas.
Clinical chemistry 1989;35(7 Suppl):B38-42.
1989: C T Fong; N C Dracopoli; P S White; P T Merrill; R C Griffith; D E Housman; Garrett M Brodeur
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3753-7.
1988: Garrett M Brodeur; Robert C Seeger; A Barrett; F Berthold; R P Castleberry; G D'Angio; B De Bernardi; A E Evans; M Favrot; A I Freeman
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1874-81.
1988: Henry S Friedman; Peter C Burger; Sandra H Bigner; John Q Trojanowski; Garrett M Brodeur; X M He; Carol J Wikstrand; Joanne Kurtzberg; Michael Berens; Edward C Halperin
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.
The American journal of pathology 1988;130(3):472-84.
1988: Garrett M Brodeur; C T Fong; M Morita; R Griffith; F A Hayes; Robert C Seeger
Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.
Progress in clinical and biological research 1988;271():3-15.